Related references
Note: Only part of the references are listed.Lentiviral vector ALS20 yields high hemoglobin levels with low genomic integrations for treatment of beta-globinopathies
Laura Breda et al.
MOLECULAR THERAPY (2021)
Northstar-2: Updated Safety and Efficacy Analysis of Lentiglobin Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia and Non-β0/β0 Genotypes
Alexis A. Thompson et al.
BLOOD (2019)
Resolution of Sickle Cell Disease Manifestations in Patients Treated with Lentiglobin Gene Therapy: Updated Results from the Phase 1/2 Hgb-206 Group C Study
Julie Kanter et al.
BLOOD (2019)
Northstar-3: Interim Results from a Phase 3 Study Evaluating Lentiglobin Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia and Either a β0 or IVS-I-110 Mutation at Both Alleles of the HBB Gene
Ashutosh Lal et al.
BLOOD (2019)
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent β-thalassemia
Sarah Marktel et al.
NATURE MEDICINE (2019)
Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with beta-Thalassemia Major
Nikoletta Psatha et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Gene Therapy in a Patient with Sickle Cell Disease
Jean-Antoine Ribeil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Lineage-specific BCL11A knockdown circumvents toxicities and reverses sickle phenotype
Christian Brendel et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Bcl11a Deficiency Leads to Hematopoietic Stem Cell Defects with an Aging-like Phenotype
Sidinh Luc et al.
CELL REPORTS (2016)
Interim Results from a Phase 1/2 Clinical Study of Lentiglobin Gene Therapy for Severe Sickle Cell Disease
Julie Kanter et al.
BLOOD (2016)
miRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F Induction
Swaroopa Guda et al.
MOLECULAR THERAPY (2015)
Establishment of Immortalized Human Erythroid Progenitor Cell Lines Able to Produce Enucleated Red Blood Cells
Ryo Kurita et al.
PLOS ONE (2013)
An Optimized microRNA Backbone for Effective Single-Copy RNAi
Christof Fellmann et al.
CELL REPORTS (2013)
Therapeutic Hemoglobin Levels after Gene Transfer in β-Thalassemia Mice and in Hematopoietic Cells of β-Thalassemia and Sickle Cells Disease Patients
Laura Breda et al.
PLOS ONE (2012)
Correction of sickle cell disease in transgenic mouse models by gene therapy
R Pawliuk et al.
SCIENCE (2001)
Share Paper
